Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Blue light can help treat skin conditions like eczema and acne without major side effects.

Some patients using cold caps to prevent hair loss from chemotherapy got mild scalp injuries similar to frostbite.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

Ban Tu Wan, a Chinese herbal supplement, can cause severe liver damage.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

JAK inhibitors show promise for treating various skin diseases.

Testosterone pellets might work for transgender men's hormone therapy, but more research is needed.

High DHEA and short cervical length in women with PCOS and recurrent miscarriages may harm pregnancy outcomes.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

L'Oréal's research and workshops have advanced understanding and tailored cosmetics for African hair and skin.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Raccoon dogs in Schleswig-Holstein, Germany, were found with sarcoptic mange, showing severe skin issues and potential for spreading the disease.

Blue light might help treat skin conditions by affecting the skin's bacteria.

Testosterone's effects on COVID-19 are unclear and need more research.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

Blocking interferon-gamma might help treat various autoimmune diseases.

The conclusion is that improved training and oversight for cosmetic procedures are recommended to better protect patients.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Tattooing guidelines focus on safety, hygiene, and following rules.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

New topical antifungals and delivery systems are improving treatment for fungal skin infections, but patient education and prevention are key.

The pandemic has pushed dermatology education and care to adopt digital solutions, which are effective and likely to continue post-pandemic.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

All medications can cause skin rashes, often without a clear cause, and better tests are needed to identify these drug-related skin issues.